KLRC1 and neoplasm: NK cells in breast tumors express high levels of NKG2A and low levels of NKp46, perforin, and granzyme B. One week of treatment with IL-12 and anti-TGF-β resulted in the increased maturation of tumor-associated NK cells (84).